High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B.
about
Dysregulation of soluble epoxide hydrolase and lipidomic profiles in anorexia nervosaResponse and recovery in the plasma metabolome tracks the acute LCMV-induced immune responseApplication of faecal metabonomics on an experimental model of tubulointerstitial fibrosis by ultra performance liquid chromatography/high-sensitivity mass spectrometry with MS(E) data collection technique.A data preprocessing strategy for metabolomics to reduce the mask effect in data analysis.Metabolic characterization of the early stage of hepatic fibrosis in rat using GC-TOF/MS and multivariate data analyses.Plasma metabolome analysis by integrated ionization rapid-resolution liquid chromatography/tandem mass spectrometry.Eating at the table of another: metabolomics of host-parasite interactions.Metabolic profiling of Escherichia coli by ion mobility-mass spectrometry with MALDI ion sourceThe metabolomic window into hepatobiliary disease.Serum metabonomics study of adenine-induced chronic renal failure in rats by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.Metabolic Profiling of Human Blood by High Resolution Ion Mobility Mass Spectrometry (IM-MS).LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.Human systems immunology: hypothesis-based modeling and unbiased data-driven approaches.Gemfibrozil disrupts lysophosphatidylcholine and bile acid homeostasis via PPARα and its relevance to hepatotoxicity.Identification of systemic immune response markers through metabolomic profiling of plasma from calves given an intra-nasally delivered respiratory vaccine.Plasma metabolite profiling and chemometric analyses of lung cancer along with three controls through gas chromatography-mass spectrometry.GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian CohortAnalysis of the Enantioselective Effects of PCB95 in Zebrafish (Danio rerio) Embryos through Targeted Metabolomics by UPLC-MS/MS.Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosisMetabolomics reveals an essential role for peroxisome proliferator-activated receptor α in bile acid homeostasis.From differentiating metabolites to biomarkers.Increased hepatocellular carcinoma risk in chronic hepatitis B patients with persistently elevated serum total bile acid: a retrospective cohort study.Systems toxicology study of doxorubicin on rats using ultra performance liquid chromatography coupled with mass spectrometry based metabolomics.Evaluation of metabolite biomarkers for hepatocellular carcinoma through stratified analysis by gender, race, and alcoholic cirrhosisSerum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated cirrhosis and carcinoma patients.QGQS Granule in SHR Serum Metabonomics Study Based on Tools of UPLC-Q-TOF and Renin-Angiotensin-Aldosterone System Form Protein Profilin-1.Metabonomics approaches and the potential application in foodsafety evaluation.Metabolomics approach to risk assessment: methoxyclor exposure in rats.Plasma metabolic profiling of dairy cows affected with clinical ketosis using LC/MS technology.Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis.A metabolomic investigation of the effects of vitamin E supplementation in humans.Effects of Shu Gan Jian Pi formula on rats with carbon tetrachloride‑induced liver fibrosis using serum metabonomics based on gas chromatography‑time of flight mass spectrometry.Metabonomic phenotype and identification of "heart blood stasis obstruction pattern" and "qi and yin deficiency pattern" of myocardial ischemia rat models.Metabolomic investigation into variation of endogenous metabolites in professional athletes subject to strength-endurance training.Metabolomics for the masses: The future of metabolomics in a personalized world.A multi-analytical approach for metabolomic profiling of zebrafish (Danio rerio) livers.Discovery of Novel Lipid Profiles in PCOS: Do Insulin and Androgen Oppositely Regulate Bioactive Lipid Production?DIVA metabolomics: Differentiating vaccination status following viral challenge using metabolomic profiles.Hepatic Metabolomics Investigation in Acute and Chronic Murine Toxoplasmosis.Metabolomics Reveals the Efficacy of Caspase Inhibition for Saikosaponin D-Induced Hepatotoxicity
P2860
Q28390115-9D0A1BA0-A0EA-4C71-AE39-6A49F3D5225EQ28727959-0597D7C8-BAD1-4953-94F9-2F0475551072Q30571181-93240A03-8B80-4E1A-B5DE-9664A8E96E58Q30953959-36FF35B9-2EB4-4609-932C-06E01BF98818Q31143019-D09D51F9-A5EE-4541-B73C-F94305FDB3BFQ33458909-1DED02F2-2E9C-4109-A922-4C3732F81892Q33671828-7D30B011-BE82-473B-87EA-2D5FC5702FE7Q33725838-D716DD58-0F15-4009-A7F1-7107822C12F1Q33893457-B5AEAE83-0DA2-4305-A31F-1BFD2ADB8F15Q34088508-BA69E1B9-37D5-433E-8F8B-0284C2B8A5BEQ34344528-F255EDC3-19FA-41A6-BBBC-4C369D9C946EQ34451211-C62D6694-8915-4417-AC14-E5854E2AAB18Q34572554-D5B81F20-937E-4AAD-9F4A-B44B1ADA0FD2Q35079707-957FD791-7E92-4013-99DE-7F540987A9FCQ35082519-674CB9AD-75BC-485B-99D0-50F7772E4445Q35119518-54B6D0E8-39C5-4BD0-9D47-BD43A26C9660Q35648370-183CBD5F-1A6B-4CC5-9AC9-51D6CAB0E62EQ36097391-63622B34-DF74-4846-8F41-51E212308BEAQ36165635-F181370E-5D25-40AD-8739-6194B6912295Q36520380-9798A1E6-F086-40EF-817B-771617C2892CQ37412408-2442F824-4892-4DB5-B7C0-76AABF333179Q37460011-0E786B92-E609-4754-9B7D-E6672F6BF115Q37478190-EF7007BC-51F5-4CBA-A448-AE118F79DFF5Q37625766-70D681A4-E235-4082-AEB7-CD591B474DA4Q37642807-A601DE71-C537-4FE4-9BF9-D75237974739Q37711748-5C27BBBB-2F49-43A0-AE7F-61F9825EB36AQ38018710-C2476BC1-7B13-4468-91E5-DA3685714B4BQ38489390-C1B81A01-21BD-4E8B-9300-5B3B79FDC04AQ39116412-A91C056F-7E2D-4F64-9029-8AA7886BC15DQ41745129-BEE3BE6F-13C0-455C-8456-4A2266820A3EQ42078937-D585EA51-1B53-4E14-A18A-16C70B8B8828Q42679542-D1506C20-D7BE-402C-B472-E3B93D5E4133Q43236039-8858234D-9E75-488A-A94B-9044B2102365Q44490270-2C8BB39C-2CE2-43B6-8B2A-6F937804FFF6Q44951888-B0F6C670-577A-4AD6-BB93-AA88F32EC057Q46118086-0A914577-0CAC-4427-A1B4-9B7F8C4FA4E3Q51304004-0B78882D-6EFC-40EE-8437-D83B19D36C19Q52604623-4D4F2FA3-CEAC-4DA7-A636-76FF6E7A0CDBQ55249468-9EB9617A-1D0C-48E2-842C-416D10F3260AQ57115200-95E8C3FA-5150-40EE-B630-A62463FFE1EE
P2860
High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
High performance liquid chroma ...... nction in chronic hepatitis B.
@en
High performance liquid chroma ...... nction in chronic hepatitis B.
@nl
type
label
High performance liquid chroma ...... nction in chronic hepatitis B.
@en
High performance liquid chroma ...... nction in chronic hepatitis B.
@nl
prefLabel
High performance liquid chroma ...... nction in chronic hepatitis B.
@en
High performance liquid chroma ...... nction in chronic hepatitis B.
@nl
P2093
P356
P1476
High performance liquid chroma ...... nction in chronic hepatitis B.
@en
P2093
Chang Wang
Guowang Xu
Jiangshan Wang
Jianren Gu
Lanjuan Li
Shengli Yang
Xiaoli Liu
Xinjie Zhao
P304
P356
10.1021/PR050364W
P577
2006-03-01T00:00:00Z